Completed PHASE4 INTERVENTIONAL 2-arm NCT00622739

Ziprasidone in Pediatric Bipolar Disorder

Ziprasidone in Pediatric Bipolar Disorder: a 6-week, Open-label Comparison of Rapid vs. Slow Dose Titration

Sponsor: Baylor College of Medicine

Interventions Ziprasidone

Updated 7 times since 2017 Last updated: Sep 30, 2019 Started: Feb 28, 2007 Primary completion: Sep 30, 2009 Completion: Nov 30, 2009

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00622739, this PHASE4 trial focuses on Bipolar Disorder and remains completed. Sponsored by Baylor College of Medicine, it has been updated 7 times since 2007, reflecting limited change activity. Mental health research at this phase helps define safety and dosing parameters for future study.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Nov 2019 — Jan 2021 [monthly]

Completed PHASE4
Jun 2018 — Nov 2019 [monthly]

Completed PHASE4

▶ Show 2 earlier versions

Feb 2017 — Jun 2018 [monthly]

Completed PHASE4
Jan 2017 — Feb 2017 [monthly]

Completed PHASE4

First recorded

Feb 2007

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Baylor College of Medicine
Children's Medical Center Dallas
Pfizer
Stanley Medical Research Institute

Data source: Baylor College of Medicine

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Dallas, United States